Search Count: 7
 |
Crystal Structure Of P38Alpha C162S In Complex With Sb20358 And Cas 2094667-81-7 (Behind Catalytic Site; Y35 In), P 21 21 21
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2023-06-14 Classification: ONCOPROTEIN Ligands: IIM, 87B |
 |
Crystal Structure Of P38Alpha C162S In Complex With Atpgs And Cas 2094667-81-7 (In Catalytic Site, Y35 Out), P 1 21 1
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2023-06-14 Classification: ONCOPROTEIN Ligands: 87B, ATP |
 |
Crystal Structure Of P38Alpha C162S In Complex With Cas2094511-69-8, P 1 21 1
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2023-05-17 Classification: ONCOPROTEIN Ligands: 8DI |
 |
An I-Motif Domain Able To Undergo Ph-Dependent Conformational Transitions (Acidic Structure)
|
 |
An I-Motif Domain Able To Undergo Ph-Dependent Conformational Transitions (Neutral Structure)
|
 |
Crystal Structure Of Plasmodium Falciparum Fabi Complexed With Nad And Inhibitor 7-(4-Chloro-2-Hydroxyphenoxy)-4-Methyl-2H-Chromen-2-One
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2013-11-06 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: CHJ, NAD, GOL, SO4 |
 |
Crystal Structure Of Plasmodium Falciparum Fabi Complexed With Nad And Inhibitor 3-(4-Chloro-2-Hydroxyphenoxy)-7-Hydroxy-2H-Chromen-2-One
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2013-11-06 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: CHV, NAD, GOL, SO4 |